期刊文献+

基于4-氟-N′-(3-乙氧基-2-羟基苯亚甲基)苯甲酰肼的甲基麦芽酚和乙基麦芽酚配位的氧钒(Ⅴ)配合物的合成、晶体结构及其类胰岛素活性(英文)

Syntheses, Crystal Structures and Insulin-like Activity of Maltolato-and Ethylmaltolato-Coordinated Oxovanadium(Ⅴ) Complexes Derived from 4-Fluoro-N′-(3-ethoxy-2-hydroxybenzylidene)benzohydrazide
下载PDF
导出
摘要 制备了一个芳酰腙化合物4-氟-N′-(3-乙氧基-2-羟基苯亚甲基)苯甲酰肼(H2L)。利用H2L和VO(acac)2分别与甲基麦芽酚(mat)和乙基麦芽酚(Emat)在甲醇中反应,得到了2个配合物[VO(L)(mat)](1)和[VO(L)(Emat)](2)。通过元素分析、红外光谱、紫外可见光谱和核磁共振氢谱表征了这些化合物的结构。通过单晶X射线衍射进一步确定了化合物的结构。芳酰腙配体以二价阴离子的方式通过酚羟基氧、亚胺基氮和烯醇氧原子与钒原子进行配位。在每个配合物中,钒都采取八面体配位构型。将配合物通过灌胃对正常的大鼠和四氧嘧啶糖尿病大鼠给药2周时间,结果表明这两个配合物在剂量为10.0和20.0 mgV·kg-1时可以显著降低四氧嘧啶糖尿病大鼠的血糖值,而对于正常大鼠的血糖值却没有改变。 A new aroylhydrazone compound 4-fluoro-N'-(3-ethoxy-2-hydroxybenzylidene)benzohydrazide (H2L) was prepared. Reaction of H2L and VO(aeae)2 with maltol(mat) and ethylmaltol(Emat), respectively, in methanol afforded the complexes [VO(L)(mat)] (1) and [VO(L)(Emat)] (2). Both H2L and the oxovanadium complexes were characterized by elemental analysis, IR, UV-Vis and JH NMR spectra. The structures of the compounds were further confirmed by single crystal X-ray diffraction. The aroylhydrazone ligand, in its dianionic form, coordinated to the V atoms through the phenolate oxygen, imino nitrogen and enolate oxygen. The maltol and ethylmaltol ligands coordinated to the V atoms through the carbonyl oxygen and deprotonated hydroxyl oxygen. The V atom in each complex is in oetahedral coordination. The complexes were administered intragastrically to both normal and alloxan-diabetic mice for two weeks. The biological activity results show that the complexes at doses of 10.0 and 20.0 mgv kg-l, can significantly decrease the blood glucose level in alloxan-diabetic mice, but the blood glucose level in the treated normal mice was not altered.
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2017年第5期905-912,共8页 Chinese Journal of Inorganic Chemistry
基金 辽宁省自然科学基金(No.2015020673) 辽宁师范大学开放实验室(No.cx20160102)资助项目
关键词 钒配合物 芳酰腙 晶体结构 类胰岛素活性 aroylhydrazone oxovanadium(V) complex crystal structure insulin-like activity
  • 相关文献

二级参考文献30

  • 1Pillai S I,Subramanian S P, Kandaswamy M. Eur. J. Med. Chem., 2013,63:109-117.
  • 2Smee J J, Epps J A, Ooms K,et al. J. Inorg. Biochem. 2009,103:575-584.
  • 3Sanna D,Micera G, Garribba E. Inorg. Chem. 2013,52: 11975-11985.
  • 4He L, Wang X S, Zhao C, et al. Metallomics, 2014,6:1087-1096.
  • 5Crans D G, Trujillo A M, Pharazyn P S, et al. Coord. Chem.Rev., 2011,255:2178-2192.
  • 6Sheela A,Roopan S M,Vijayaraghavan R. Eur. J. Med. Chem. 2008,43:2206-2210.
  • 7Zhang Y,Yang X D, Wang K, et al. J. Inorg. Biochem. 2006,100:80-87.
  • 8Domyei A, Marcao S, Pessoa J C, et al. Eur. J. Inorg. Chem., 2006,18:3614-3621.
  • 9Haratake M, Fukunaga M, Ono M, et al. J. Biol. Inorg. Chem., 2005,10:250-258.
  • 10McNeill J H, Yuen V G, Hoveyda H R, et al. J. Med. Chem., 1992,35:1489-1491.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部